Toni Weinschenk und Steffen Walter - Info zur Person

(1 - 13 von 14

)

Neue Angriffspunkte für Impfung gegen Hirntumor – Innovations Report

www.innovations-report.de

... Verona Vass, Steffen Walter, Paul R. Walker, Toni Weinschenk, Harpreet Singh-Jasuja and Pierre-Yves Dietrich. Brain (2012) doi: brain/aws042

Close Biotechgate Biotechgate | | Twitter LinkedIn Google+ ...

spanishbiotech.com

Immatics US, Inc. is led by Harpreet Singh (Chief Executive Officer), Steffen Walter (Chief Scientific Officer), Toni Weinschenk (Chief Technology Officer) and Carsten Reinhardt (Chief Medical Officer). Immatics US, Inc. is based in Houston, Texas. About Immatics Biotechnologies GmbH. Immatics Biotechnologies GmbH is a ...

immatics Launches US Subsidiary with $60M, MD Anderson ...

www.genengnews.com

— Rounding out immatics US' management team are CSO Steffen Walter, CTO Toni Weinschenk, and CMO Carsten Reinhardt. immatics US said it aims ... › dr...

IMA901, a multipeptide cancer vaccine, plus sunitinib versus ...

www.em-consulte.com

... Jens Fritsche, PhD, Toni Weinschenk, PhD, Steffen Walter, PhD, Alexandra Kirner, PhD, Harpreet Singh-Jasuja, PhD, Carsten Reinhardt, MD, Tim Eisen, FRCP. › im...

Tumor Immunology and Immunotherapy

books.google.gr

... vaccines for clinical application Harpreet Singh-Jasuja, Toni Weinschenk, and Steffen Walter.

SCHATTENBLICK - ONKOLOGIE/1313: Glioblastom - Neue Angriffspunkte für...

www.schattenblick.de

... Jens Fritsche, Peter Lewandrowski, Jennifer Lohr, Hans-Georg Rammensee, Stefan Stevanovic, Claudia Trautwein, Verona Vass, Steffen Walter, Paul R. Walker, Toni Weinschenk

Neue Angriffspunkte für Impfung gegen Hirntumor

www.dkfz.de

... Verona Vass, Steffen Walter, Paul R. Walker, Toni Weinschenk, Harpreet Singh-Jasuja and Pierre-Yves Dietrich. Brain (2012) doi: brain/aws

IMA901, a multipeptide cancer vaccine, plus sunitinib versus...

eprints.soton.ac.uk

von BI Rini · · Zitiert von: 166 — Author: Toni Weinschenk. Author: Steffen Walter. Author: Alexandra Kirner. Author: Harpreet Singh-Jasuja. Author: Carsten Reinhardt. Author: Tim Eisen ... › ...

IMMATICS AKTIE Unternehmensprofil | Aktionärsstruktur

www.finanzen.net

Peter Alan Chambré Chairman. Rainer Kramer Chief Business Officer. Steffen Walter Chief Technology Officer. Toni Weinschenk Chief Innovation Officer ... › unternehmensprofil › immat...

Immune Tolerance to Tumor Antigens Occurs in a Specialized...

moh-it.pure.elsevier.com

Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen. Stefano Ugel, Elisa Peranzoni, Giacomo Desantis, Mariacristina Chioda, Steffen Walter, Toni Weinschenk, Jordi C. Ochando, Anna Cabrelle, Susanna Mandruzzato, Vincenzo Bronte. Istituto Oncologico Veneto.